LifeScan, Inc.是血糖监测领域的全球领导者，其愿景是为糖尿病患者创造一个无限制世界。全球超过2000万患者使用OneTouch®品牌产品帮助他们更好地管理糖尿病。超过35年来，LifeScan一直致力于通过开发简单、准确和值得信赖的产品，改善糖尿病患者的生活质量。详情请访问：http:\/\/www.lifescan.com\/<\/a> 和 http:\/\/www.onetouch.com\/<\/a>。<\/p> \n

\n \n \n \n \n \n \n \n

^{1<\/sup> Setford等人合撰。“来自长期系统性后市场监测计划的证据；对红细胞压积不敏感的血糖试纸的临床表现”(Evidence from a Long-term, Systematic Post-Market Surveillance Program; Clinical Performance of a Haematocrit Insensitive Blood Glucose Test-Strip)。《Journal of Diabetes Science and Technology》<\/em>(2019) 1-9<\/span><\/p> <\/td> \n <\/tr> \n}
<\/td> \n <\/tr> \n

^{2<\/sup> Annette Baumstark博士、Nina Jendrike医学博士、Stefan Pleus理学硕士、Christina Liebing 博士、Cornelia Haug医学博士和Guido Freckmann医学博士合撰。“基于ISO 15197:2013标准对三个批次的试纸进行新的血糖自我监测系统的准确性评估”(Accuracy evaluation of a new system for self-monitoring of blood glucose with three test strip lots based on ISO 15197:2013)<\/em>。《Journal of Diabetes Science and Technology》<\/em>(2017) 1-2 <\/span><\/p> <\/td> \n <\/tr> \n}
<\/td> \n <\/tr> \n

^{3<\/sup> Setford等人合撰。“血糖试纸产品临床表现的七年监测”(Seven-year surveillance of the clinical performance of a blood glucose test strip product)。《Journal of Diabetes Science and Technology》<\/em>(2017) 1-8<\/span><\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div> \n}
<\/p>"]; $("#dvExtra").html(content_array[0]);})();